Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Seelos Therapeutics Inc
(NQ:
SEEL
)
0.5341
-0.0258 (-4.61%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Seelos Therapeutics Inc
< Previous
1
2
...
11
12
13
14
15
16
17
18
Next >
Psychedelic Stock Gainers And Losers From January 20, 2022
January 20, 2022
GAINERS: Small Pharma (OTC:
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
January 20, 2022
During Thursday's morning trading, 152 companies set new 52-week lows. Noteworthy Points From Today's 52-Week Lows: Rivian Automotive (NASDAQ:RIVN) was the largest...
Via
Benzinga
Revive Therapeutics, GH Research Among Top Psychedelic Movers Of Today
January 19, 2022
GAINERS: Revive Therapeutics (OTC:
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
January 19, 2022
During Wednesday's morning trading, 400 companies set new 52-week lows. 52-Week Low Highlights: Intuitive Surgical (NASDAQ:ISRG) was the largest company by...
Via
Benzinga
Psychedelic Stock Gainers And Losers From January 18, 2022
January 18, 2022
GAINERS: Cybin (AMEX:
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
January 14, 2022
During Friday's session, 445 companies made new 52-week lows. Noteable 52-Week Lows: Intuitive Surgical (NASDAQ:ISRG) is the largest company in terms of market cap to...
Via
Benzinga
Pure-Play Marijuana- & Psychedelic Compounds-Based Drug Stocks Index Is Down By 66% From 2021 High
January 09, 2022
There are 16 remaining constituents of our Marijuana & Psychedelic Compounds-Based Drug Stocks Index is now DOWN -65.9% from its highs in 2021. Here are the details for each of its constituents.
Via
Talk Markets
The Year In Review For Psychedelic Drug Stocks: 2021
December 21, 2021
2021 was two different
Via
Talk Markets
12 Health Care Stocks Moving In Friday's After-Market Session
December 10, 2021
Gainers Quoin Pharmaceuticals (NASDAQ:
Via
Benzinga
Singapore Based iX Biopharma Hands Seelos Exclusive Rights For Wafermine For Pain Management
November 24, 2021
iX Biopharma has inked an exclusive agreement to license its lead drug under development, Wafermine, to Seelos Therapeutics Inc (NASDAQ: SEEL). Seelos...
Via
Benzinga
Seelos Therapeutics To Test Trehalose In Patients With Rare Movement Control Disorder
November 08, 2021
The FDA has accepted Seelos Therapeutics Inc's (NASDAQ: SEEL) Investigation New Drug application to study SLS-005 (trehalose injection, 90.5 mg/mL) for...
Via
Benzinga
Exposures
Product Safety
Biotech Companies Are Embracing the Growing Psychedelic Drug Market To Confront a Global Increase in Depression and Anxiety
October 27, 2021
Image by 3D Animation Production Company from Pixabay The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team...
Via
Benzinga
B. Riley Sees 'Significant Potential' In This Beaten-Up Biotech Stock
October 21, 2021
B. Riley analyst calls Seelos Therapeutics Inc (NASDAQ:
Via
Benzinga
Forget The Hype: The Psychedelic Stocks Sector Went Down In The Third Quarter Of 2021
October 15, 2021
Despite the prevailing hype, the psychedelic sector went down considerably last quarter (July through September) and has gone down even further so far this month.
Via
Talk Markets
COVID Tests, THC Patches, Psychedelics: Xphyto Therapeutics Does it All
October 04, 2021
Image by Shameer Pk from Pixabay From 25-minute COVID-19 lab tests to psychedelic medicine that is poised to address mental health conditions like PTSD, XPhyto Therapeutics (...
Via
Benzinga
Exposures
COVID-19
Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation
October 18, 2021
The Week In Psychedelics
Via
Benzinga
September Summary: Cannabis-Based Vs. Psychedelic Compounds-Based Drug Stock Performances
October 01, 2021
Which index out-performed in September, the Pure-Play Marijuana-Based Drug Stocks Index or the Pure-Play Psychedelic Compounds-Based Drug Stocks Index?
Via
Talk Markets
Why This Seelos Therapeutics Analyst Is Turning Bullish On Potential Trial Results
September 27, 2021
Part A results from the trial of Seelos Therapeutics Inc’s (NASDAQ:
Via
Benzinga
There Are Now 50 Psychedelics Companies Listed In The U.S. - Here They Are
October 13, 2021
Just two years ago, the psychedelics sector was a small research space reserved for academics and extremely forward-thinking investors. S...
Via
Benzinga
Mid-Afternoon Market Update: Dow Gains 150 Points; Red Cat Holdings Shares Spike Higher
September 27, 2021
Toward the end of trading Monday, the Dow traded up 0.43% to 34,949.08 while the NASDAQ fell 0.35% to 14,995.27. The S&P also fell, dropping 0.05% to 4,453.40. The U.S. has...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Seelos Therapeutics Stock Is Trading Higher Today
September 27, 2021
Seelos Therapeutics Inc (NASDAQ:SEEl) is trading higher Monday after Roth Capital analyst Jonathan Aschoff upgraded the stock from Neutral to Buy and raised the price...
Via
Benzinga
50 Biggest Movers From Yesterday
September 28, 2021
Gainers Red Cat Holdings, Inc. (NASDAQ: RCAT) shares surged 50% to close at $3.60 on Monday after the company said its subsidiary, Skypersonic, Inc, won a five-year contract from...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
September 27, 2021
Gainers Keros Therapeutics (NASDAQ:KROS) stock moved upwards by 26.51% to $41.75 during Monday's regular session. Keros Therapeutics's stock is trading at a volume...
Via
Benzinga
31 Stocks Moving In Monday's Mid-Day Session
September 27, 2021
Gainers Red Cat Holdings, Inc. (NASDAQ: RCAT) shares jumped 54.1% to $3.6998 after the company said its subsidiary, Skypersonic, Inc, won a five-year contract from NASA to...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 27, 2021
September 27, 2021
Upgrades According to Roth Capital, the prior rating for Seelos Therapeutics Inc (NASDAQ:
Via
Benzinga
Seelos Therapeutics Shares Gain On FDA Approval To Add SLS-005 Regimen In HEALEY ALS Trial
September 21, 2021
The Sean M. Healey & AMG Center for ALS at Mass General received approval from the FDA and the Mass General Brigham Institutional Review Board to add SLS-005 (...
Via
Benzinga
Exposures
Product Safety
Why Seelos Therapeutics' Stock Is Trading Higher Today
September 21, 2021
Seelos Therapeutics (NASDAQ:SEEL) shares are trading higher. Traders are circulating a Massachusetts General Hospital report titled 'Investigational drug SLS-005 (...
Via
Benzinga
Psychedelic Medicine's Top CEOs: Who's Running The Biggest Companies In This Booming Industry?
September 09, 2021
By Natan Ponieman and Javier Hasse The psychedelic medicine industry is growing by leaps and bounds. Leading this charge is a group of ambitious and visionary corporate...
Via
Benzinga
Psychedelic Drug Industry Report Card For 2021
September 01, 2021
In assessing the psychedelic drug industry, a primary focus for investors is drug development.
Via
Talk Markets
25 Stocks Moving in Monday's Pre-Market Session
August 23, 2021
Gainers Greenpro Capital Corp. (NASDAQ: GRNQ) rose 48.7% to $1.13 in pre-market trading. Greenpro Capital shares gained 16% on Friday after the company announced its Angkasa-X...
Via
Benzinga
< Previous
1
2
...
11
12
13
14
15
16
17
18
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.